CAS: 211096-49-0 - N-(2-Bromophenyl)-N'-(4-cyano-1H-1,2,3-benzotriazol-7-yl)urea
Formula:C14H9BrN6O
- Synonyms:
- Sb-265610
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Urea, N-(2-bromophenyl)-N'-(4-cyano-1H-benzotriazol-7-yl)- REF: IN-DA002L5GCAS: 211096-49-0 | 98% | To inquire | Thu 13 Feb 25 |
 | SB-265610 REF: TM-T16850CAS: 211096-49-0 | 97.67% | 55.00 €~1,612.00 € | Thu 20 Feb 25 |
 | SB-265610 REF: 3D-LIA09649CAS: 211096-49-0 | Min. 95% | To inquire | Thu 27 Mar 25 |
Urea, N-(2-bromophenyl)-N'-(4-cyano-1H-benzotriazol-7-yl)-
CAS:211096-49-0
Formula:
C14H9BrN6O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
357.1649
Ref: IN-DA002L5G
| 1mg | 88.00 € | ||
| 25mg | 195.00 € | ||
| 50mg | 237.00 € | ||
| 100mg | 533.00 € |
Estimated delivery in United States, on Thursday 13 Feb 2025
SB-265610
CAS:211096-49-0
SB-265610 (GSK-CXCR2) is a nonpeptide and allosteric CXCR2 antagonist.
Formula:
C14H9BrN6O
Purity:
97.67%
Color and Shape:
Solid
Molecular weight:
357.16
Ref: TM-T16850
| 1mg | 55.00 € | ||
| 5mg | 118.00 € | ||
| 10mg | 184.00 € | ||
| 25mg | 370.00 € | ||
| 50mg | 550.00 € | ||
| 100mg | 786.00 € | ||
| 500mg | 1,612.00 € | ||
| 1mL*10mM (DMSO) | 130.00 € |
Estimated delivery in United States, on Thursday 20 Feb 2025
SB-265610
CAS:211096-49-0
SB-265610 is a selective inhibitor of the EGF receptor, which binds to the epidermal growth …
Formula:
C14H9BrN6O
Purity:
Min. 95%
Molecular weight:
357.16 g/mol
Ref: 3D-LIA09649
| 25mg | 1,190.00 € | ||
| 50mg | 1,656.00 € |
Estimated delivery in United States, on Thursday 27 Mar 2025
